Viking Therapeutics, Inc. (VKTX)

33.00 +1.49 (+4.73%) USD  |  NASDAQ  |  Mar 06, 16:00
33.16 +0.16 (+0.48%) After-Hours: 16:54
More

Viking Therapeutics Allow for Loan/Lease Loss (Quarterly)

Allow for Loan/Lease Loss (Quarterly) Chart

View Allow for Loan/Lease Loss (Quarterly) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Allow for Loan/Lease Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Allow for Loan/Lease Loss (Quarterly) Range, Past 5 Years

View Allow for Loan/Lease Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Allow for Loan/Lease Loss (Quarterly) Benchmarks

View Allow for Loan/Lease Loss (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Pfizer Inc. --
Amgen, Inc. --
Hims & Hers Health, Inc. --
Altimmune, Inc. --